Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Scientist Behind China CRISPR-Cas9 Scandal Sentenced to Three Years in Prison

publication date: Dec 30, 2019

Jiankui He, the Shenzhen scientist who used CRISPR-Cas9 gene editing to alter the embryos of seven IVF patients, was sentenced to three years in prison and a fine of $430,000. Dr. He maintains he used gene editing to disable the CCR5 gene that allows HIV to enter cells. The researcher was accused of avoiding standard procedures for protecting patients in an attempt to become the first scientist to perform the procedure. Dr. He pleaded guilty and is banned for life from providing assisted reproductive services. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital